Text to go here...
The UK Bioscience sector prepared a submission of supplementary evidence to the House of Lords European Union Committee, Sub –Committee D (Environment and Agriculture) on the revision of Directive 86/609.
This follows an earlier submission, in May 2009, and a number of new developments, including the oral evidence sessions and emerging conclusions of the inquiry, meetings between the UK Bioscience Sector and the Commission, developments in the Council Working Group, and the publication of the full Prognos impact assessment on the Commission website.
It encompasses the views of a number of organisations, including umbrella organisations, that represent academia, industry, SMEs, charities and other research funders in the United Kingdom, all of which will be directly affected by the revision of the Directive. Issues covered in the submission include public opinion, international competition, severity classification, restrictions to research on non-human primates and alternative methods.
Last edited: 11 January 2022 09:02